Hoth Therapeutics Inc HOTH:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/17/24 EDT
1.20quote price arrow up+0.02 (+1.69%)
Volume
1,003
Close
1.18quote price arrow down-0.01 (-0.84%)
Volume
18,383
52 week range
0.99 - 4.30
Loading...
  • Open1.18
  • Day High1.20
  • Day Low1.17
  • Prev Close1.19
  • 52 Week High4.30
  • 52 Week High Date06/06/23
  • 52 Week Low0.99
  • 52 Week Low Date11/15/23

Key Stats

  • Market Cap5.769M
  • Shares Out4.89M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta0.79
  • YTD % Change-18.06

KEY STATS

  • Open1.18
  • Day High1.20
  • Day Low1.17
  • Prev Close1.19
  • 52 Week High4.30
  • 52 Week High Date06/06/23
  • 52 Week Low0.99
  • 52 Week Low Date11/15/23
  • Market Cap5.769M
  • Shares Out4.89M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta0.79
  • YTD % Change-18.06

RATIOS/PROFITABILITY

  • EPS (TTM)-2.02
  • P/E (TTM)-0.58
  • Fwd P/E (NTM)-0.71
  • EBITDA (TTM)-7.554M
  • ROE (TTM)-78.21%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Hoth Therapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); a treatment for traumatic brain injury and ischemic stroke (HT-TBI) and a treatment and/or prevention for Alzheimer’s or other neuroinflammatory diseases (HT-ALZ). It also has assets being developed for...
Robb Knie
President, Chief Executive Officer, Director
David Briones
Chief Financial Officer
Address
590 Madison Avenue, 21St Floor
New York, NY
10022
United States

Top Peers

SYMBOLLASTCHG%CHG
ATXI
Avenue Therapeutics Inc
3.73+0.10+2.75%
PCSA
Processa Pharmaceuticals Inc
1.96-0.04-2.00%
ADIL
Adial Pharmaceuticals Inc
1.55+0.14+9.93%
BPTH
Bio Path Holdings Inc
2.14-0.20-8.55%
TOVX
Theriva Biologics Inc
0.3707-0.0033-0.8824%